MedTrace Logo

Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line

NCT00804453 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-03-13

No results posted yet for this study

Summary

The primary objective is to collect data to evaluate the biocompatibility of two types of blood circuit, already on the market.

Conditions

  • Chronic Kidney Failure

Interventions

DEVICE

Cartridge blood set

Once a week

DEVICE

Standard blood line

Once a week

Sponsors & Collaborators

  • Gambro Lundia AB

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Principal Investigators

  • Walid Arkouche, Dr · AURAL dialysis centre Lyon France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804453 on ClinicalTrials.gov